Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind study of solithromycin (T-4288) vs levofloxacin in community-acquired pneumonia
jRCT2080222672Phase 2
- Sponsor
- Fujifilm
- Start
- Nov 2014
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of solithromycin in community-acquired pneumonia (CAP) (2 arms), sponsored by Fujifilm.
02
Drugs
solithromycin
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on jRCT2080222672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222672.